Oxford Biomedica Share Price | |
---|---|
Price | 471.00 |
Bid | 471.00 |
Ask | 473.50 |
Change | -5.00 (-1.05%) |
Volume | 4,190 |
Open | 478.50 |
High | 478.50 |
Low | 471.00 |
Prev. Close | 476.00 |
Currency | GBX |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 96m |
Market Capitalisation | £453m |
Market Size | 2,000 |
52 Week High | 1,678.00 |
52 Week High Date | 24-Sep-2021 |
52 Week Low | 414.00 |
52 Week Low Date | 17-Jun-2022 |
# Trades | 21 |
---|---|
Vol. Sold | 1,912 |
Sold Value | £9,027.31 |
Vol. Bought | 2,278 |
Bought Value | £10,821.88 |
PE Ratio | 20.685 |
Earnings | 22.77 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
28-Jun-22 | 09:35:43 | 471.00 | 4 | Sell* | 471.00 | 474.00 | 18.84 | A Automatic Execution |
28-Jun-22 | 09:29:10 | 473.50 | 35 | Buy* | 471.00 | 474.00 | 165.73 | A Automatic Execution |
28-Jun-22 | 09:26:42 | 473.395 | 90 | Buy* | 471.00 | 473.50 | 426.06 | O Ordinary |
28-Jun-22 | 09:18:45 | 472.416 | 526 | Buy* | 470.50 | 472.50 | 2,485 | O Ordinary |
28-Jun-22 | 09:04:40 | 472.7488 | 423 | Buy* | 470.50 | 473.00 | 2,000 | O Ordinary |
28-Jun-22 | 08:59:51 | 468.95 | 1,051 | Sell* | 468.00 | 472.50 | 4,929 | O Ordinary |
28-Jun-22 | 08:36:19 | 471.50 | 134 | Buy* | 467.50 | 471.50 | 631.81 | A Automatic Execution |
28-Jun-22 | 08:36:19 | 471.50 | 116 | Buy* | 467.50 | 471.50 | 546.94 | A Automatic Execution |
28-Jun-22 | 08:33:15 | 473.9975 | 417 | Buy* | 469.50 | 474.50 | 1,977 | O Ordinary |
28-Jun-22 | 08:20:40 | 474.00 | 29 | Sell* | 472.50 | 476.00 | 137.46 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
29-Apr-22 | 29-Apr-22 | Buy | Catherine Moukheibir held the position of Independent Non-Executive Director at the time of this trade. Catherine Moukheibir | 571.00 | GBX | 2,467 | 2,467 |
21-Apr-22 | 21-Apr-22 | Buy | Roch Doliveux held the position of Chairman and CEO at the time of this trade. Roch Doliveux | 589.00 | GBX | 58,219 | 273,678 |
21-Apr-22 | 20-Apr-22 | Buy | Roch Doliveux held the position of Chairman and CEO at the time of this trade. Roch Doliveux | 536.00 | GBX | 29,000 | 273,678 |
20-Apr-22 | 20-Apr-22 | Buy | Stuart Paynter held the position of CFO at the time of this trade. Stuart Paynter | 508.00 | GBX | 3,915 | 14,657 |
29-Sep-21 | 29-Sep-21 | Buy | Michael Hayden held the position of Non-Executive Director at the time of this trade. Michael Hayden | 1,507.50 | GBX | 1,910 | 1,910 |